CD27 peptide
CD27 peptide is a 13-amino acid peptide derived from CD27. CD27 peptide is a targeting ligand for CD70 and can be used to construct CD70-targeted peptide amphiphile micelles. CD27 peptide can be used for research on melanoma and clear cell renal cell carcinoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3037125-72-4
- Formule: C54H92N18O17S3
- Masse moléculaire:1361.61
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
In Vivo
-
Animal Model:C57BL/6 (Female human CD27 transgenic (hCD27), aged 6-12 weeks)[2]
-
Dosage:100 µg
-
Administration:i.p.; on days 3 and 6 after tumor implantation
-
Result:Increased Ova(I)-specific CD8+ T cells from ~20% to ~50% of the CD8+ TIL population.
Extended median survival by 18 days compared to control animals.\nProlonged survival in the setting of vaccines comprised of linked class I and II epitopes (Ova(I-IIA)).
Had no effect on survival with Ova(I) or Ova(I) + Ova(IIA) vaccines.\nProlonged survival in hCD27 mice bearing intracranial B16.OVA tumors.
-
Animal Model:C57BL/6 (Female human CD27 transgenic (hCD27), aged 6-12 weeks)[2]
-
Dosage:100 µg
-
Administration:i.p.; on days 3 and 6 after tumor implantation
-
Result:Prolonged survival in mice bearing 3-day established intracranial B16.F10 tumors when combined with Trp2(I)-P30.
Had no effect on survival relative to control groups when combined with Trp2(I).
Chemical Information
-
CAS No. 3037125-72-4
-
Masse moléculaire 1361.61
-
Formule C54H92N18O17S3
-
Sequence
Cys-Arg-Lys-Ala-Ala-Gln-Cys-Asp-Pro-Cys-Ile-Pro-Gly
-
Sequence Shortening
CRKAAQCDPCIPG
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)